The participants are healthy people..
Conditions
Interventions
Intervention 1: Intervention group: Taking N-acetylcysteine ??supplements (manufactured by Hakim Pharmaceutical Company, licensed by the Food and Drug Administration
in the form of effervescent tablets, 1800 mg (three 600 mg tablets) with a glass of water 45 minutes before the start of the Wingate test) and then performing a standard 30-second Wingate test. Interv
Sponsors
Razi University
Eligibility
Sex/Gender
Female
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Female students majoring in Physical Education and Sports Sciences, third semester or higher Not taking any sports supplements for two months prior to the start of the study. Age range 18 to 30 years Body mass index (BMI) 18.5 to 24.9 kilograms per square of height in meters
Exclusion criteria
Exclusion criteria: Suffering from various cardiovascular, pulmonary, and metabolic diseases History of seizures, epilepsy, or other types of neurological diseases Tobacco and alcohol use Pregnancy or breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anaerobic performance. Timepoint: 45 minutes after taking N-acetylcysteine ??or placebo supplements, during and after a 30-second Wingate test. Method of measurement: Using the standard 30-second Wingate lower body test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain index. Timepoint: One minute after performing anaerobic activity. Method of measurement: Visual analog scale 0_10.;Anxiety. Timepoint: Five minutes after performing anaerobic activity. Method of measurement: Adjective-mood questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactVahid Tadibi
Razi University
Outcome results
None listed